Comparative immunohistochemical analysis of inflammatory cytokines in distinct subtypes of Sweet syndrome

Front Immunol. 2024 Mar 11:15:1355681. doi: 10.3389/fimmu.2024.1355681. eCollection 2024.

Abstract

Background: A dysregulated immune response has been implicated in Sweet syndrome (SS) pathogenesis; however, cytokine profiles across different conditions associated with SS - including adult-onset immunodeficiency (AOID) due to anti-interferon (IFN)-γ autoantibodies - remain unknown.

Objective: To investigate alterations in inflammatory cytokines in skin lesions of distinct subtypes of SS.

Methods: Skin biopsies were collected from 42 AOID- and 52 non-AOID-associated SS patients and 18 healthy controls. The comparative immunohistochemical study was conducted using monoclonal antibodies against interleukin (IL)-1β, IL-6, IL-17, IFN-γ, and tumor necrosis factor-α on paraffin-embedded sections. The quantitative percentage positivity and intensity were calculated using computer-based image analysis.

Results: The results showed stronger and more diffuse dermal immunoreactivity for IFN-γ and IL-17 in the AOID-associated (p < 0.001 and p < 0.001, respectively) and non-AOID-associated SS (p < 0.001 and p < 0.001, respectively) groups. However, no significant differences in the levels of these two cytokines were observed between the AOID- and non-AOID-associated SS groups. Increased expression of IFN-γ together with IL-17 was also noted in almost all subtypes among non-AOID-associated SS.

Conclusions: These results demonstrate that IFN-γ and IL-17 are implicated in immunopathology of all SS subtypes, including AOID-associated SS, despite the presence of anti-IFN-γ autoantibodies.

Keywords: adult-onset immunodeficiency; anti-IFN-γ autoantibody; cytokine expression; immunohistochemical staining; sweet syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Autoantibodies
  • Cytokines* / metabolism
  • Humans
  • Interleukin-17
  • Sweet Syndrome*
  • Tumor Necrosis Factor-alpha

Substances

  • Cytokines
  • Interleukin-17
  • Autoantibodies
  • Tumor Necrosis Factor-alpha

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by Faculty of Medicine, Chiang Mai University, Thailand (Grant Number: MED-2563-07187).